Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ee6eb9f680459e710dcaca03f8d54ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ff8e195bdee373b70c3907b72939f9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e491e5f8cd845e48cd7d3c03b132e26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7ae3c307113fccecfa83471a77de554 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
filingDate |
2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb69fca9ab3b0b7abea061eab08c04fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e168476d232294c3e00139a10bd22415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59befd7ed18c55282f27bbbb4f50dd5 |
publicationDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004110367-A2 |
titleOfInvention |
Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
abstract |
An isolated and/or purified Sdr surface protein from S. capitis and nucleic acids encoding them are provided which includes the SdrX protein which possesses collagen binding activites and the SdrZL protein which possesses SdrZ-like properties. The Sdr surface proteins from S. capitis can be used in pharmaceutical compositions to treat and prevent S. capitis infectionm and can also be used in vaccines and to raise antibodies which can treat or prevent such infections. Because the SdrX protein has been shown to have collagen binding abilities, antibodies to SdrX will have the ability to inhibit or prevent the ability of S. capitis to bind to collagen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458228-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9399673-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2368570-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9688745-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9927428-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8389682-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105440133-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008088822-A1 |
priorityDate |
2003-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |